Extrahepatic tissues compensate for loss of hepatic taurine synthesis in mice with liver-specific knockout of cysteine dioxygenase

被引:37
|
作者
Ueki, Iori [1 ]
Roman, Heather B. [1 ]
Hirschberger, Lawrence L. [1 ]
Junior, Carolyn [1 ]
Stipanuk, Martha H. [1 ]
机构
[1] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA
关键词
sulfur amino acids; sulfate; glutathione; GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; CYSTATHIONINE BETA-SYNTHASE; SULFUR AMINO-ACIDS; INTRACELLULAR CYSTEINE; PROTEASOME SYSTEM; METABOLISM; ENZYMES; GLUTATHIONE; PROTEIN; DECARBOXYLASE;
D O I
10.1152/ajpendo.00589.2011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ueki I, Roman HB, Hirschberger LL, Junior C, Stipanuk MH. Extrahepatic tissues compensate for loss of hepatic taurine synthesis in mice with liver-specific knockout of cysteine dioxygenase. Am J Physiol Endocrinol Metab 302: E1292-E1299, 2012. First published March 13, 2012; doi:10.1152/ajpendo.00589.2011.-Because hepatic cysteine dioxygenase (CDO) appears to play the major role in controlling cysteine catabolism in the intact rat, we characterized the effect of a lack of hepatic CDO on the regulation of cysteine and its metabolites at the whole body level. In mice with liver-specific deletion of CDO expression, hepatic and plasma cysteine levels increased. In addition, in mice with liver-specific deletion of CDO expression, the abundance of CDO and the proportion of CDO existing as the mature, more active isoform increased in extrahepatic tissues that express CDO (kidney, brown fat, and gonadal fat). CDO abundance was also increased in the pancreas, where most of the enzyme in both control and liver CDO-knockout mice was in the more active isoform. This upregulation of CDO concentration and active-site cofactor formation were not associated with an increase in CDO mRNA and thus presumably were due to a decrease in CDO degradation and an increase in CDO cofactor formation in association with increased exposure of extrahepatic tissues to cysteine in mice lacking hepatic CDO. Extrahepatic tissues of liver CDO-knockout mice also had higher levels of hypotaurine, consistent with increased metabolism of cysteine by the CDO/cysteinesulfinate decarboxylase pathway. The hepatic CDO-knockout mice were able to maintain normal levels of glutathione, taurine, and sulfate. The maintenance of taurine concentrations in liver as well as in extrahepatic tissues is particularly notable, since mice were fed a taurine-free diet and liver is normally considered the major site of taurine biosynthesis. This redundant capacity for regulation of cysteine concentrations and production of hypotaurine/taurine is additional support for the body's robust mechanisms for control of body cysteine levels and indicates that extrahepatic tissues are able to compensate for a lack of hepatic capacity for cysteine catabolism.
引用
收藏
页码:E1292 / E1299
页数:8
相关论文
共 50 条
  • [41] LIVER-SPECIFIC β-CATENIN KNOCKOUT MICE EXHIBIT CHOLESTASIS AND INCREASED SUSCEPTIBILITY TO BILE ACID-INDUCED LIVER INJURY
    Behari, Jaideep
    Yeh, Tzu-Hsuan
    Krauland, Lindsay K.
    Zou, Baobo
    Monga, Satdarshan
    HEPATOLOGY, 2009, 50 (04) : 664A - 664A
  • [42] DISREGULATED IRON AND LIPID METABOLISM IN MICE WITH LIVER-SPECIFIC KNOCKOUT OF IRON CHAPERONE PCBP1
    Protchenko, Olga
    Li, Fengmin
    Shakoury-Elizeh, Minoo
    Ghosh, Manik C.
    Gavrilova, Oksana
    Philpott, Caroline C.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E202 - E202
  • [43] No evidence for an indirect effect of insulin to suppress glucose production in liver-specific insulin receptor knockout mice
    Fisher, SJ
    Kahn, CR
    DIABETES, 2001, 50 : A50 - A50
  • [44] Inducibility of Drug-Metabolizing Enzymes by Xenobiotics in Mice with Liver-Specific Knockout of Ctnnb1
    Braeuning, Albert
    Sanna, Riccardo
    Huelsken, Joerg
    Schwarz, Michael
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (05) : 1138 - 1145
  • [45] Amelioration of Hypercholesterolemia by an EGFR Tyrosine Kinase Inhibitor in Mice with Liver-Specific Knockout of Mig-6
    Lee, Jun Choul
    Park, Byung Kil
    Choung, Sorim
    Kim, Ji Min
    Joung, Kyong Hye
    Lee, Ju Hee
    Kim, Koon Soon
    Kim, Hyun Jin
    Jeong, Jae-Wook
    Dal Rhee, Sang
    Ku, Bon Jeong
    PLOS ONE, 2014, 9 (12):
  • [46] Liver-specific loss of β-catenin blocks glutamine synthesis pathway activity and cytochrome P450 expression in mice
    Sekine, S
    Lan, BYA
    Bedolli, M
    Feng, S
    Hebrok, M
    HEPATOLOGY, 2006, 43 (04) : 817 - 825
  • [47] Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice
    Dentin, Renaud
    Benhamed, Fadila
    Hainault, Isabelle
    Fauveau, Veronique
    Foufelle, Fabienne
    Dyck, Jason R. B.
    Girard, Jean
    Postic, Catherine
    DIABETES, 2006, 55 (08) : 2159 - 2170
  • [48] Liver-specific Prox1 inactivation causes hepatic injury and glucose intolerance in mice
    Goto, Toshihiko
    Elbahrawy, Ashraf
    Furuyama, Kenichiro
    Horiguchi, Masashi
    Hosokawa, Shinichi
    Aoyama, Yoshiki
    Tsuboi, Kunihiko
    Sakikubo, Morito
    Hirata, Koji
    Masui, Toshihiko
    Kubo, Hajime
    Sakai, Yoshiharu
    Uemoto, Shinji
    Kawaguchi, Yoshiya
    FEBS LETTERS, 2017, 591 (04): : 624 - 635
  • [49] Liver-Specific Knockout of GRP94 in Mice Disrupts Cell Adhesion, Activates Liver Progenitor Cells, and Accelerates Liver Tumorigenesis
    Chen, Wan-Ting
    Tseng, Chun-Chih
    Pfaffenbach, Kyle
    Kanel, Gary
    Luo, Biquan
    Stiles, Bangyan L.
    Lee, Amy S.
    HEPATOLOGY, 2014, 59 (03) : 947 - 957
  • [50] Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice
    Harada, Naomoto
    Oda, Zenjun
    Hara, Yoshikazu
    Fujinami, Koji
    Okawa, Mayumi
    Ohbuchi, Katsuya
    Yonemoto, Mari
    Ikeda, Yuika
    Ohwaki, Kenji
    Aragane, Katsumi
    Tamai, Yoshitaka
    Kusunoki, Jun
    MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (05) : 1881 - 1888